All You Need to Know About Applied Therapeutics (APLT) Rating Upgrade to Buy
ZacksApplied Therapeutics (APLT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company’s earnings prospects. This might drive the stock higher in the near term.